Curative Health Insurance Raises $150M Series B to Expand AI-Powered $0 Out-of-Pocket Plan

Curative Health Insurance Company has secured over $150 million in Series B funding, boosting its valuation to $1.25 billion. This capital injection is aimed at advancing Curative's innovative health plan that offers $0 out-of-pocket costs for members who complete an annual preventative health appointment known as the Baseline Visit. The funding will also support Curative's national expansion, particularly targeting mid-Atlantic states, building on its existing presence in Texas, Florida, and Georgia. The Series B round was led by TED chairman Chris Anderson's Upside Vision Fund, with significant contributions from Justin Mateen's JAM Fund and other investors including Mike Novogratz of Galaxy Digital, Stanley Druckenmiller's Duquesne Family Office, DCVC, and Martin Varsavsky. These funds will be utilized to strengthen reserves to meet state regulatory compliance requirements and ensure the company maintains robust long-term financial strength ratings. Investments will also focus on enhancing member engagement through AI-driven support, expanding network affiliations, improving operational efficiencies, and implementing modernized alternative payment methods. Curative's plan has demonstrated significant positive outcomes, such as a 20% increase in primary care participation, a 30% reduction in hospital admissions, and up to 40% lower medication costs within the first year for members. Since its launch less than three years ago, Curative has grown to serve over 1,200 employer clients and more than 165,000 members. The company's CEO, Fred Turner, highlighted that their model combines AI technology with human support and aligned incentives to improve health outcomes and modernize the member experience. The new funding round enables Curative to accelerate its growth and expand its impact within the competitive health insurance landscape.